These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 22903612)
1. Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cells. Heidegger I; Ofer P; Doppler W; Rotter V; Klocker H; Massoner P Endocrinology; 2012 Oct; 153(10):4633-43. PubMed ID: 22903612 [TBL] [Abstract][Full Text] [Related]
2. Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis. Heidegger I; Kern J; Ofer P; Klocker H; Massoner P Oncotarget; 2014 May; 5(9):2723-35. PubMed ID: 24809298 [TBL] [Abstract][Full Text] [Related]
3. Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo. Ofer P; Heidegger I; Eder IE; Schöpf B; Neuwirt H; Geley S; Klocker H; Massoner P Mol Endocrinol; 2015 Dec; 29(12):1694-707. PubMed ID: 26452103 [TBL] [Abstract][Full Text] [Related]
4. Expression of the IGF axis is decreased in local prostate cancer but enhanced after benign prostate epithelial differentiation and TGF-β treatment. Massoner P; Ladurner Rennau M; Heidegger I; Kloss-Brandstätter A; Summerer M; Reichhart E; Schäfer G; Klocker H Am J Pathol; 2011 Dec; 179(6):2905-19. PubMed ID: 21983635 [TBL] [Abstract][Full Text] [Related]
5. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line. Raja Singh P; Arunkumar R; Sivakamasundari V; Sharmila G; Elumalai P; Suganthapriya E; Brindha Mercy A; Senthilkumar K; Arunakaran J Cell Biochem Funct; 2014 Apr; 32(3):217-28. PubMed ID: 23963693 [TBL] [Abstract][Full Text] [Related]
6. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells. Sarfstein R; Nagaraj K; LeRoith D; Werner H Cells; 2019 Nov; 8(12):. PubMed ID: 31771180 [TBL] [Abstract][Full Text] [Related]
7. Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors. Chen J; Nagle AM; Wang YF; Boone DN; Lee AV J Biol Chem; 2018 Mar; 293(10):3700-3709. PubMed ID: 29330302 [TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells. Xuan S; Szabolcs M; Cinti F; Perincheri S; Accili D; Efstratiadis A J Biol Chem; 2010 Dec; 285(52):41044-50. PubMed ID: 20947509 [TBL] [Abstract][Full Text] [Related]
9. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Ahearn TU; Peisch S; Pettersson A; Ebot EM; Zhou CK; Graff RE; Sinnott JA; Fazli L; Judson GL; Bismar TA; Rider JR; Gerke T; Chan JM; Fiorentino M; Flavin R; Sesso HD; Finn S; Giovannucci EL; Gleave M; Loda M; Li Z; Pollak M; Mucci LA; Carcinogenesis; 2018 Dec; 39(12):1431-1437. PubMed ID: 30165429 [TBL] [Abstract][Full Text] [Related]
10. Glucose concentration and AMP-dependent kinase activation regulate expression of insulin receptor family members in rat islets and INS-1E beta cells. Raile K; Klammt J; Laue S; Garten A; Blüher M; Kralisch S; Klöting N; Kiess W Diabetologia; 2005 Sep; 48(9):1798-809. PubMed ID: 16052330 [TBL] [Abstract][Full Text] [Related]
11. Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. Rochester MA; Riedemann J; Hellawell GO; Brewster SF; Macaulay VM Cancer Gene Ther; 2005 Jan; 12(1):90-100. PubMed ID: 15499378 [TBL] [Abstract][Full Text] [Related]
12. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells. Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001 [TBL] [Abstract][Full Text] [Related]
13. The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer. Ibuki N; Ghaffari M; Reuveni H; Pandey M; Fazli L; Azuma H; Gleave ME; Levitzki A; Cox ME Mol Cancer Ther; 2014 Dec; 13(12):2827-39. PubMed ID: 25267499 [TBL] [Abstract][Full Text] [Related]
14. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306 [TBL] [Abstract][Full Text] [Related]
15. Involvement of Igf1r in Bronchiolar Epithelial Regeneration: Role during Repair Kinetics after Selective Club Cell Ablation. López IP; Piñeiro-Hermida S; Pais RS; Torrens R; Hoeflich A; Pichel JG PLoS One; 2016; 11(11):e0166388. PubMed ID: 27861515 [TBL] [Abstract][Full Text] [Related]
16. IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer. Neuzillet Y; Chapeaublanc E; Krucker C; De Koning L; Lebret T; Radvanyi F; Bernard-Pierrot I BMC Cancer; 2017 Sep; 17(1):636. PubMed ID: 28882129 [TBL] [Abstract][Full Text] [Related]